🔴 Nanobiotix is trading 5% down

Nanobiotix is trading at $29.57, down 5.09%; no clear company-specific announcement explaining the October 1 decline surfaced in the search.

• Nanobiotix’s investor-relations releases list its September 14 clinical update as the latest release.
• An October 1 report described continued technical selling pressure but did not establish a direct cause for this U.S.-listed move.
• The provided major-index moves were each below 0.5%, so broad-market direction alone does not clearly explain the decline.